
ResearchAndMarkets.com released a comprehensive report analyzing over 1,230 bioinformatics collaboration and licensing deals from 2019 to 2026. The report offers detailed insights into deal structures, including upfront payments, milestones, royalties, and contract terms, helping companies benchmark transactions and negotiate partnerships effectively. It highlights how data, algorithms, and technology platforms drive dealmaking in bioinformatics, providing transparency on rights, responsibilities, and financial arrangements. This resource supports strategic decision-making and valuation in a data-driven biotech market.